Petmed Express Stock Cash Flow From Operations
| PQM Stock | EUR 4.20 0.06 1.41% |
PetMed Express fundamentals help investors to digest information that contributes to PetMed Express' financial success or failures. It also enables traders to predict the movement of PetMed Stock. The fundamental analysis module provides a way to measure PetMed Express' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to PetMed Express stock.
PetMed |
PetMed Express Company Cash Flow From Operations Analysis
PetMed Express' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current PetMed Express Cash Flow From Operations | 18.5 M |
Most of PetMed Express' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, PetMed Express is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, PetMed Express has 18.5 M in Cash Flow From Operations. This is 97.25% lower than that of the Consumer Defensive sector and 97.99% lower than that of the Pharmaceutical Retailers industry. The cash flow from operations for all Germany stocks is 98.1% higher than that of the company.
PetMed Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses PetMed Express' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics of similar companies.PetMed Express is currently under evaluation in cash flow from operations category among its peers.
PetMed Fundamentals
| Return On Equity | 0.0831 | |||
| Return On Asset | 0.0524 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.05 % | |||
| Current Valuation | 290.33 M | |||
| Shares Outstanding | 21.08 M | |||
| Shares Owned By Insiders | 4.29 % | |||
| Shares Owned By Institutions | 82.51 % | |||
| Price To Earning | 9.60 X | |||
| Price To Book | 2.78 X | |||
| Price To Sales | 1.44 X | |||
| Revenue | 273.42 M | |||
| Gross Profit | 78.08 M | |||
| EBITDA | 28.45 M | |||
| Net Income | 21.1 M | |||
| Cash And Equivalents | 100.53 M | |||
| Cash Per Share | 4.91 X | |||
| Current Ratio | 6.79 X | |||
| Book Value Per Share | 6.57 X | |||
| Cash Flow From Operations | 18.5 M | |||
| Earnings Per Share | 0.53 X | |||
| Target Price | 32.0 | |||
| Number Of Employees | 212 | |||
| Beta | 0.65 | |||
| Market Capitalization | 367.6 M | |||
| Total Asset | 176.32 M | |||
| Z Score | 1.0 | |||
| Annual Yield | 0.06 % | |||
| Five Year Return | 3.28 % | |||
| Net Asset | 176.32 M | |||
| Last Dividend Paid | 1.2 |
About PetMed Express Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze PetMed Express's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in PetMed Stock
When determining whether PetMed Express is a strong investment it is important to analyze PetMed Express' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact PetMed Express' future performance. For an informed investment choice regarding PetMed Stock, refer to the following important reports:Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in PetMed Express. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in PetMed Stock please use our How to Invest in PetMed Express guide.You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.